Iodide

Iodide

SCHEMBL17555144

C[N+](C)(Cc1ccc(CNC(=O)C2=Cc3cc(Br)ccc3OC2)cc1)C1CCOCC1.[I-]

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CCR2 P41597 5/20 0.69
▸ MAPT P10636 5/20 0.63
▸ TP53 P04637 3/20 0.63
▸ LMNA P02545 1/20 0.63
▸ CCR5 P51681 9/20 0.53
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ HSP90AA1 P07900 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2692635 0.99 CCR2 (0.70) CCR2MAPTTP53LMNACCR5
Hydrochloric Acid SCHEMBL2903301 0.98 CCR2 (0.69) CCR2MAPTTP53LMNACCR5
Iodide SCHEMBL17555185 0.90 CCR2 (0.85) CCR2CCR5
SCHEMBL4456644 0.89 CCR2 (0.87) CCR2CCR5
Hydrochloric Acid SCHEMBL2696183 0.88 CCR2 (0.85) CCR2CCR5
SCHEMBL13148343 0.82 CCR5 (0.62) CCR2CCR5
Hydrochloric Acid SCHEMBL313749 0.82 CCR5 (0.63) CCR2CCR5
Iodide SCHEMBL17555182 0.81 CCR2 (0.72) CCR2MAPTTP53LMNACCR5
SCHEMBL13148273 0.80 CCR2 (0.73) CCR2MAPTTP53LMNACCR5
Iodide SCHEMBL17555098 0.80 CCR2 (0.51) CCR2MAPTTP53CCR5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765803-B1 QUATERNARY SALT CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2016-03-09 — — EP disclosed
Send feedback